PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Clinical trial NCT07611214 · RECRUITING
Trial details
- NCT number
- NCT07611214
- Sponsor
- Aurinia Pharmaceuticals Inc.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-22
- Primary completion
- 2029-03-02
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.